Cited by 116Mobile Health and mHealth ApplicationsDiabetes Management and EducationDiabetes Management and Research

Improved Medication Adherence and Frequency of Blood Glucose Self-Testing Using an m-Health Platform Versus Usual Care in a Multisite Randomized Clinical Trial Among People with Type 2 Diabetes in India

Kleinman, Nora J., Shah, Avani, Shah, Sanjiv, Phatak, Sanjeev, Viswanathan, Vijay·2017·Telemedicine and e-Health

Abstract

BACKGROUND: In 2015, India had an estimated 69.2 million people with diabetes and a national prevalence of 8.7%. Evidence is mounting for the benefits of telemedicine in diabetes care, but remains limited on mobile-health (m-Health) interventions. INTRODUCTION: This study assessed the impact of an m-Health diabetes platform on clinical outcomes, patient-reported outcomes, patient and provider satisfaction, and app usage. MATERIALS AND METHODS: This open-label, two-arm parallel study enrolled 91 people at 3 sites in India, aged 18-65, with type 2 diabetes, and an A1c between 7.5% and 12.5% (58-113 mmol/mol). Participants were randomly assigned 1:1 to m-Health or usual care and observed for 6 months. All received free visits, laboratory tests, transportation fees, and strips and lancets. Intervention participants received the m-Health app and a mobile phone data stipend. RESULTS: A1c change was previously reported as statistically significant. Significantly more participants in intervention than control had improved medication adherence (39.0% vs. 12.8%; p = 0.03) and increased frequency of blood glucose (BG) self-testing (39.0% vs. 10.3%; p = 0.01) at 6 months from baseline. No other outcomes were significantly different. Among m-Health users, 75% of participants actively used the app at week 24. Participants entered 29,668 medications and 2,575 BG readings, sent 497 messages, and received 890 messages. Most participants (80%) were satisfied with all aspects of the app and all seven providers rated the software very acceptable. DISCUSSION: Participants assigned to m-Health had increased medication adherence and frequency of BG testing compared with usual care participants. CONCLUSIONS: This tool could be an effective way to expand access to quality chronic disease care and improve outcomes.

Integrity signals

Registry

Crossref · 10.1089/tmj.2016.0265

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kleinman, N. J., Shah, A., Shah, S., Phatak, S., & Viswanathan, V.
Affiliations
  • Gather Health LLC, Hong Kong.
  • Diabetes Action Centre, Mumbai, India.
  • DHL Research Centre, Ahmedabad, India.
  • Prof. M. Viswanathan Diabetes Research Centre, Chennai, India.
Corresponding author
Kleinman, Nora J.
Venue
Telemedicine and e-Health
Published
2017-09
Volume
23
Issue
9
Pages
733-740
ISSN
  • 1530-5627 (ISSN-L)
  • 1556-3669
OpenAlex
W2598477829
Cited by
116
References
27
Citations by year
2026: 10 · 2025: 11 · 2024: 15 · 2023: 22 · 2022: 9 · 2021: 19 · 2020: 12 · 2019: 6 · 2018: 9 · 2017: 3
FWCI
13.24
Type
journal article
Language
en
Open access
closed
Locations
  • Telemedicine Journal and e-Health (publishedVersion)
  • PubMed (publishedVersion)
Funders
Diabetes Action Research and Education Foundation
Topics
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 2 diabetes, mobile health, medication adherence, self-monitoring of blood glucose, glycemic control, HbA1c, telemedicine, diabetes self-management, patient satisfaction, app usage, chronic care, India
MeSH terms
Patient Reported Outcome Measures, Adolescent, Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, India, Male, Middle Aged, Self Care, Socioeconomic Factors, Drug Monitoring, Patient Satisfaction, Young Adult, Mobile Applications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review